These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9482109

  • 1. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.
    Wang L, Darling J, Zhang JS, Qian CP, Hartmann L, Conover C, Jenkins R, Smith DI.
    Oncogene; 1998 Feb 05; 16(5):635-42. PubMed ID: 9482109
    [Abstract] [Full Text] [Related]

  • 2. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW, Le Beau MM.
    Cancer Res; 2002 Jun 15; 62(12):3477-84. PubMed ID: 12067991
    [Abstract] [Full Text] [Related]

  • 3. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.
    Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, Wilke C, Glover TW, Vaitkevicius VK, Smith DI.
    Cancer Res; 1996 Oct 01; 56(19):4347-50. PubMed ID: 8813121
    [Abstract] [Full Text] [Related]

  • 4. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K.
    Cancer Res; 1997 Mar 15; 57(6):1166-70. PubMed ID: 9067288
    [Abstract] [Full Text] [Related]

  • 5. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 7. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P, Wilhelm M, Kovacs G.
    Genes Chromosomes Cancer; 1997 Sep 01; 20(1):9-15. PubMed ID: 9290948
    [Abstract] [Full Text] [Related]

  • 8. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D, Beer DG, Wilke CW, Miller DE, Glover TW.
    Oncogene; 1997 Oct 02; 15(14):1653-9. PubMed ID: 9349498
    [Abstract] [Full Text] [Related]

  • 9. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.
    Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, Mullins C, Sakr W, Grignon D, Miller OJ, Sun QC, Petros J, Smith DI.
    Oncogene; 1997 Mar 20; 14(11):1269-77. PubMed ID: 9178887
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 20; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 11. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines.
    Kastury K, Baffa R, Druck T, Ohta M, Cotticelli MG, Inoue H, Negrini M, Rugge M, Huang D, Croce CM, Palazzo J, Huebner K.
    Cancer Res; 1996 Mar 01; 56(5):978-83. PubMed ID: 8640789
    [Abstract] [Full Text] [Related]

  • 12. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints.
    Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, Hoge A, Glover TW, Smith DI.
    Genomics; 1996 Jul 01; 35(1):87-93. PubMed ID: 8661108
    [Abstract] [Full Text] [Related]

  • 13. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 14. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST, Fong KM, Bader SA, Minna JD, Le Beau MM, McKeithan TW, Rassool FV.
    Genes Chromosomes Cancer; 1997 Sep 01; 20(1):16-23. PubMed ID: 9290949
    [Abstract] [Full Text] [Related]

  • 15. Common fragile sites and cancer (review).
    Smith DI, Huang H, Wang L.
    Int J Oncol; 1998 Jan 01; 12(1):187-96. PubMed ID: 9454904
    [Abstract] [Full Text] [Related]

  • 16. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma.
    Wilke CM, Guo SW, Hall BK, Boldog F, Gemmill RM, Chandrasekharappa SC, Barcroft CL, Drabkin HA, Glover TW.
    Genomics; 1994 Jul 15; 22(2):319-26. PubMed ID: 7806217
    [Abstract] [Full Text] [Related]

  • 17. Evidence that instability within the FRA3B region extends four megabases.
    Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI.
    Oncogene; 2002 Dec 12; 21(57):8713-22. PubMed ID: 12483524
    [Abstract] [Full Text] [Related]

  • 18. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K.
    Cancer Res; 1997 Feb 01; 57(3):504-12. PubMed ID: 9012482
    [Abstract] [Full Text] [Related]

  • 19. The role of the FHIT/FRA3B locus in cancer.
    Huebner K, Garrison PN, Barnes LD, Croce CM.
    Annu Rev Genet; 1998 Feb 01; 32():7-31. PubMed ID: 9928473
    [Abstract] [Full Text] [Related]

  • 20. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C, Jackson A, Maguire K, Wood J, Gollin S, Ishwad C, Paterson I, Prime S, Parkinson K, Bell S, Woods G, Markham A, Oliver R, Woodward R, Sloan P, Dixon M, Read A, Thakker N.
    Genes Chromosomes Cancer; 2003 Jun 01; 37(2):132-40. PubMed ID: 12696061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.